Finance

Beta
Lists
TOI:NASDAQ
Oncology Institute Inc
$5.07
+4.11%
(+0.20) 1D
$5.13
+1.25% (+0.063)
After hours
Closed: Jun 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TOI...
Open
$5.08
High
$5.58
Low
$4.99
Mkt. cap
506.91M
Avg. vol.
1.73M
Volume
3.01M
52-wk high
$5.58
52-wk low
$2.02
EPS
-$0.38
Beta
0.35
Shares outstanding
99.98M
No. of employees
641
Open
$5.08
High
$5.58
Low
$4.99
Mkt. cap
506.91M
Avg. vol.
1.73M
Volume
3.01M
52-wk high
$5.58
52-wk low
$2.02
EPS
-$0.38
Beta
0.35
Shares outstanding
99.98M
No. of employees
641
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to TOI in the past 3 months
Strong Buy
Buy
4
Hold
0
Sell
0
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for TOI in the last 3 months.
Highest
Current $5.07
$8.00 (+57.79%)
Average
$7.25 (+43.00%)
Lowest
$5.00 (-1.38%)
News stories
From sources across the web
About Oncology Institute Inc
CEO-
Employees641
Founded2007
HeadquartersCerritos, California, United States
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
119.80M
136.56M
141.96M
147.44M
Cost of goods sold
102.30M
117.64M
119.19M
124.13M
Cost of revenue
102.30M
117.64M
119.19M
124.13M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.91M
25.25M
28.04M
28.21M
Operating expense
28.71M
26.97M
29.67M
29.83M
Total operating expenses
131.01M
144.62M
148.86M
153.95M
Operating income
-11.21M
-8.05M
-6.91M
-6.51M
Other non operating income
-4.06M
-6.53M
1.31M
5.96M
EBT including unusual items
-17.14M
-16.50M
-7.51M
-2.49M
EBT excluding unusual items
-17.14M
-16.50M
-7.51M
-2.49M
Income tax expense
-131.00K
-
-
-
Effective tax rate
0.76%
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.01M
-16.50M
-7.51M
-2.49M
Net profit margin
-14.20%
-12.09%
-5.29%
-1.69%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.87M
-1.92M
-1.92M
-1.93M
Net interest expenses
-1.87M
-1.92M
-1.92M
-1.93M
Depreciation and amortization charges
1.80M
1.72M
1.63M
1.62M
EBITDA
-9.41M
-6.33M
-5.28M
-4.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more